Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) EBT Margin (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed EBT Margin for 16 consecutive years, with 314976.19% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 32726381.0% to 314976.19% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3399.76% through Sep 2025, down 543180.0% year-over-year, with the annual reading at 31.15% for FY2024, 339695.0% up from the prior year.
  • EBT Margin hit 314976.19% in Q4 2025 for Perspective Therapeutics, down from 18034.03% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 12287.62% in Q4 2024 to a low of 314976.19% in Q4 2025.
  • Historically, EBT Margin has averaged 18674.72% across 5 years, with a median of 438.08% in 2023.
  • Biggest five-year swings in EBT Margin: soared 1184541bps in 2024 and later tumbled -32726381bps in 2025.
  • Year by year, EBT Margin stood at 56.96% in 2021, then crashed by -316bps to 236.92% in 2022, then skyrocketed by 287bps to 442.21% in 2023, then soared by 2679bps to 12287.62% in 2024, then tumbled by -2663bps to 314976.19% in 2025.
  • Business Quant data shows EBT Margin for CATX at 314976.19% in Q4 2025, 18034.03% in Q3 2025, and 12864.91% in Q2 2025.